Assembly Biosciences (NASDAQ:ASMB) Now Covered by Guggenheim
Guggenheim initiated coverage on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a report released on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $31.00 price target on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on ASMB. HC Wainwright reissued a “neutral” rating on […]
Guggenheim initiated coverage on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a report released on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $31.00 price target on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on ASMB. HC Wainwright reissued a “neutral” rating on […]
